1-3 of 3
Hillary Millar
Close
Sort by
Journal Articles

Development of Multi-Engineered iPSC-Derived CAR-NK Cells for the Treatment of B-Cell Malignancies

Luis Borges, Mark A Wallet, Chiamin-Liao Bullaughey, Michael F Naso, Buddha Gurung, Shelby Keating, Jill M Carton, John C Wheeler, Liam Campion, Mark Mendonca, Heidi K Jessup, Marilda Beqiri, Diana Chin, Hillary Millar Quinn, Barry A Morse
Journal: Blood
Blood (2021) 138 (Supplement 1): 1729.
https://doi.org/10.1182/blood-2021-148438
Published: 2021
Journal Articles

Induced Pluripotent Stem Cell-Derived Gamma Delta CAR-T Cells for Cancer Immunotherapy

Mark A Wallet, Toshinobu Nishimura, Christina Del Casale, Andriana Lebid, Brenda Salantes, Katherine Santostefano, Sydney Bucher, Mark Mendonca, Marilda Beqiri, Lucas J Thompson, Barry A Morse, Hillary Millar Quinn, Luis Borges
Journal: Blood
Blood (2021) 138 (Supplement 1): 2771.
https://doi.org/10.1182/blood-2021-149095
Published: 2021
Journal Articles

Development of a CD123xCD3 Bispecific Antibody (JNJ-63709178) for the Treatment of Acute Myeloid Leukemia (AML)

François Gaudet, Jennifer F Nemeth, Ronan McDaid, Yingzhe Li, Benjamin Harman, Hillary Millar, Alexey Teplyakov, John Wheeler, Jinquan Luo, Susan Tam, Sheng-Jiun Wu, Emily Chen, Stephen Rudnick, Gerald Chu, Anna Hughes, Leopoldo Luistro, Diana Chin, Alexander Babich, Anna Kalota, Indrajeet Singh, Mark Salvati, Yusri Elsayed, Ricardo M. Attar
Journal: Blood
Blood (2016) 128 (22): 2824.
https://doi.org/10.1182/blood.V128.22.2824.2824
Published: 2016